Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 3,000 shares at $122.88 ($369K) on 2017-06-26, disclosed to the SEC on 2017-06-27.
Seasonal sale ($369k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.88 | 2,600 | $319K | 86.6% |
| 2 | $123.66 | 400 | $49K | 13.4% |
| Total | $122.98 avg | 3,000 | $369K | 100% |
| Filing → |
| ACN | SELL | 2017-12-27 | $573K | — | Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-04-28 | $329K | — | Filing → |